Výsledky vyhledávání - "F Leal, da Costa"

Akademický článek

Improving Health Outcomes Through Treatment Sequencing Optimization in Multiple Myeloma: A Simulation Model in Transplant‐Ineligible Patients

Autor: C. Geraldes, M. Neves, R. Bergantim, C. Silva, F. Leal da Costa

Publikováno v: Cancer Reports, Vol 7, Iss 10, Pp n/a-n/a (2024)

ABSTRACT Objectives Patients with multiple myeloma often require multiple treatment lines. The order in which treatments are sequenced has impact on clinical outcomes. This study aimed to estimate progression‐free survival (PFS) and overall surviva

Externí odkaz: https://doaj.org/article/5ec3579d45d0433c978aa89ef692b67a

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The mediator role of unmet needs on quality of life in myeloma patients

Autor: Carlos Alberto Gonçalves, H Marques, H Coelho, Maria da Graça Pereira, Sara Monteiro, Magda Simone Leite Pereira, Carlos F. G. C. Geraldes, Rosário Bacalhau, Gabriela Ferreira, F Leal da Costa, Margarida Vilaça

Publikováno v: Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP

The diagnosis of multiple myeloma (MM) has a significant impact on patients. This study analyzed the mediating role of patients’ unmet needs in the relationship between psychological morbidity/social support and quality of life (QoL). Methods This

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b62612f657b525c0ce46cefd06630e73
https://hdl.handle.net/10400.16/2705

Zobrazit plný text záznamu

Optimizing the use of lenalidomide in relapsed or refractory multiple myeloma: consensus statement

Autor: Fe. Davies, Jesús F. San-Miguel, Antonio Palumbo, H. Einsele, Ma Dimopoulos, Pieter Sonneveld, F. Leal da Costa, Roman Hájek, Meral Beksac, Gareth J. Morgan, U. H. Mellqvist, Heinz Ludwig, Michel Delforge, Sonja Zweegman, M. Attal, J L Harousseau

Publikováno v: Leukemia, 25(5), 749-760. Nature Publishing Group
Digital.CSIC. Repositorio Institucional del CSIC
instname
Dimopoulos, M A, Palumbo, A, Attal, M, Beksac, M, Davies, F E, Delforge, M, Einsele, H, Hajek, R, Harousseau, J L, Da Costa, F L, Ludwig, H, Mellqvist, U H, Morgan, G J, San-Miguel, J F, Zweegman, S & Sonneveld, P 2011, ' Optimizing the use of lenalidomide in relapsed or refractory multiple myeloma: consensus statement ', Leukemia, vol. 25, no. 5, pp. 749-760 . https://doi.org/10.1038/leu.2011.3

An expert panel convened to reach a consensus regarding the optimal use of lenalidomide in combination with dexamethasone (Len/Dex) in patients with relapsed or refractory multiple myeloma (RRMM). On the basis of the available evidence, the panel agr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c7f0692125938c919a427bfc3e1ed9e
https://hdl.handle.net/1765/26387

Zobrazit plný text záznamu

Ancestim (recombinant human stem cell factor, SCF) in association with filgrastim does not enhance chemotherapy and/or growth factor-induced peripheral blood progenitor cell (PBPC) mobilization in patients with a prior insufficient PBPC collection

Autor: José Luís Passos-Coelho, S Sousa, J Antas, M. G. Da Silva, P. Pimentel, Alzira Carvalhais, Isabela Marim Barbosa, A Campos, F. Leal da Costa, A. Machado, Carlos Pinho Vaz, Fernando Campilho, Nuno Miranda

Publikováno v: Bone marrow transplantation. 34(8)

Up to a third of autologous transplantation candidates fail to mobilize hematopoietic progenitors into the peripheral blood with chemotherapy and/or growth factor treatment, thus requiring innovative mobilization strategies. In total, 20 cancer patie

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9a73086f951ec6a385a362822e8e363
https://pubmed.ncbi.nlm.nih.gov/15806123

Zobrazit plný text záznamu

Autologous peripheral stem cell transplantation for multiple myeloma in a patient with a 10 year-old kidney transplant: case report and clinical issues

Autor: F, Rego, P, Alcântara, F, Buinho, F, Araújo, J M, Santos, A, Parreira, F Leal, da Costa

Publikováno v: Transplantation proceedings. 35(3)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::6897afcf166fc022a9d17c353b2583f7
https://pubmed.ncbi.nlm.nih.gov/12947876

Zobrazit plný text záznamu

Akademický článek

Procainamide, oxprenolol and amiodarone as antidysrhythmic drugs in myocardial infarction.

Autor: J. L. Tuna, M. J. Correia, V. Corrêa d'Almeida, L. Mourão, F. Leal da Costa, C. Ribeiro

Publikováno v: Acta Médica Portuguesa, Vol 2 (1980)

Using Holter recordings and based on the principle that most of the survivors of acute myocardial infarction who are going to die suddenly after hospital discharge are those who present ventricular premature beats (VPB), the authors have studied the

Externí odkaz: https://doaj.org/article/8e6531dbeda949d49d6f3d10f3e8aa89

Zobrazit plný text záznamu

Congenital amegakaryocytic thrombocytopenia—Report of a newc-mpl gene missense mutation

Autor: Manuel Abecasis, A. Reichert, A Guimarães, Nuno Miranda, José Luís Passos-Coelho, M. Sebastião, L Vieira, Isabelina Ferreira, F. Leal-da-Costa, P. Gameiro

Publikováno v: American Journal of Hematology. 82:240-241

A 44-month old girl with congenital amegakaryocytic thrombocytopenia, already with pancytopenia, underwent an unrelated allogeneic cord blood transplantation with recovery of normal blood cell counts. The patient was a compound heterozygote for two c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e563727154287659dbd24b0f50689567
https://doi.org/10.1002/ajh.20756

Zobrazit plný text záznamu

Clinical outcome of germ cell cancer patients (pts) treated with high-dose chemotherapy with stem cell support (HDC) –a single center experience

Autor: Ana Vera Machado, Nuno Miranda, André Raimundo Guimarães, Manuel Abecasis, Isabel C.F.R. Ferreira, E. G. Dos Santos, José Luís Passos-Coelho, F. Leal-da-Costa

Publikováno v: Journal of Clinical Oncology. 22:4724-4724

4724 Background: Pts with International Germ Cell Cancer Collaborative Group (IGCCCG) “poor prognosis” disease achieve only a 41% 5-year progression-free survival (PFS) with standard chemotherapy. Pts who do not achieve a complete remission with

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0e19c29e9b63c5c2ca63ac2f1624ec02
https://doi.org/10.1200/jco.2004.22.90140.4724

Zobrazit plný text záznamu

Reversible acute renal failure following single administration of fludarabine

Autor: R Nunes, M Nave, Miguel Abecasis, F. Leal da Costa, José Luís Passos-Coelho, Nuno Miranda

Publikováno v: Bone Marrow Transplantation. 33:671-671

Fludarabine is a purine analogue with high activity in lymphoid malignancies and a frequent component of reduced-intensity conditioning regimens, due to its immunosuppressive properties. Renal toxicity of fludarabine occurs in less than 5% of patient

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e42051029622e6ebe5fc0c4f7211fa1b
https://doi.org/10.1038/sj.bmt.1704404

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání